Locoregional treatment of primary tumor in synchronous metastatic head and neck squamous cell carcinomas-Reference-Cited by-同舟云学术

Locoregional treatment of primary tumor in synchronous metastatic head and neck squamous cell carcinomas

Published:2023-05-04 Issue:5 Volume:62 Page:465-472
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Tang Eliane¹^ORCID,Schwartz Boris²,Limkin Elaine¹,Even Caroline³,Blanchard Pierre¹,Haddy Nadia²,Gorphe Philippe⁴,Ferrand François-Régis³,Tao Yungan¹,Nguyen Thanh-Van-France¹^ORCID

Affiliation:

1. Department of Radiation Oncology, Gustave Roussy, Villejuif, France

2. Department of Radiation Epidemiology, Unité 1018 INSERM, Gustave Roussy, Villejuif, France

3. Department of Head and Neck Oncology, Gustave Roussy, Villejuif, France

4. Department of Head and Neck Surgery, Gustave Roussy, Villejuif, France

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2209266

Reference21 articles.

1. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment

2. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

3. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

4. Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

5. Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma